The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

In a head-to-head study, three continuous glucose monitoring systems showed different measurements in the same person, which ...

Here are four promising growth stocks that can help increase the value of your investment portfolio. The post Looking for ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness ...

Nick Jonas has given a surprising update on his diabetes journey.The Jonas Brothers member was diagnosed with type 1 diabetes ...

These developments provided a positive counterbalance amidst a... DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience and ...